Xavant Technology has partnered with clinical leaders of advanced Quantitative Neuromuscular Blockade Monitoring and developed an educational program to understand the clinical benefits of this technology.
As part of our ongoing educational series, you will learn how objective NMT Monitoring can support you in your critical decision-making process.
Prof Heidi Lewald takes us through the background and evidence of residual neuromuscular block, followed by Dr Grant Rodney looking at the clinical practice and strategy behind monitoring for residual neuromuscular block.
You can learn more about the STIMPOD NMS450X here, the only handheld Multi-Sensor TOF Monitor.
Consultant Anaesthetist @Ninewells Hospital, Dundee, Scotland